3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
21
Myelodysplastic Syndromes
7
Leukemia
7
Leukemia, Myelomonocytic, Chronic
5
Recurrence
4
Melanoma
4
Congenital Abnormalities
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Neoplasms
2
Neoplasm Metastasis
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Blast Crisis
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pancreatic Adenocarcinoma Metastatic
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Mesothelioma, Malignant
1
Interventions
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Pancreatic Adenocarcinoma Metastatic
×
Decitabine
×
Clear all
NCT05360264
2025-03-24
ORIENTATE
Regina Elena Cancer Institute
Phase 2
Terminated
7 enrolled